Skip to main content
. 2017 Oct 4;8(52):90197–90214. doi: 10.18632/oncotarget.21644

Figure 3. Fagan diagram evaluating the positive likelihood ratio (PLR) and negative likelihood ratio (NLR).

Figure 3